Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution.

Alves MG, Oliveira PF, Martins FO, Oliveira PJ, Carvalho RA.

J Cardiovasc Pharmacol. 2012 Feb;59(2):151-7. doi: 10.1097/FJC.0b013e3182391d17.

PMID:
21983744
2.

Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution.

Alves MG, Oliveira PF, Martins FO, Oliveira PJ, Carvalho RA.

J Cardiovasc Pharmacol. 2012 Aug;60(2):227-33. doi: 10.1097/FJC.0b013e3182391d17.

PMID:
22892386
3.

Substrate selection in hearts subjected to ischemia/reperfusion: role of cardioplegic solutions and gender.

Alves MG, Oliveira PJ, Carvalho RA.

NMR Biomed. 2011 Nov;24(9):1029-37. doi: 10.1002/nbm.1640. Epub 2011 Jan 28.

PMID:
21274961
4.

Mitochondrial preservation in Celsior versus histidine buffer solution during cardiac ischemia and reperfusion.

Alves MG, Oliveira PJ, Carvalho RA.

Cardiovasc Toxicol. 2009 Dec;9(4):185-93. doi: 10.1007/s12012-009-9052-4. Epub 2009 Sep 15.

PMID:
19757201
5.

Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation.

Rudd DM, Dobson GP.

J Thorac Cardiovasc Surg. 2011 Dec;142(6):1552-61. doi: 10.1016/j.jtcvs.2011.05.023. Epub 2011 Jul 13.

6.

Anti-apoptotic protection afforded by cardioplegic celsior and histidine buffer solutions to hearts subjected to ischemia and ischemia/reperfusion.

Alves MG, Machado NG, Sardão VA, Carvalho RA, Oliveira PJ.

J Cell Biochem. 2011 Dec;112(12):3872-81. doi: 10.1002/jcb.23320.

PMID:
21866562
7.

Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C.

Ackemann J, Gross W, Mory M, Schaefer M, Gebhard MM.

Ann Thorac Surg. 2002 Aug;74(2):522-9.

PMID:
12173839
8.

A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia.

Boku N, Tanoue Y, Kajihara N, Eto M, Masuda M, Morita S.

J Heart Lung Transplant. 2006 Feb;25(2):219-25. Epub 2005 Dec 20.

PMID:
16446224
9.

Comparative effects of Celsior and a new cardioplegic solution on function, energy metabolism, and intracellular pH during long-term heart preservation.

Desrois M, Caus T, Lan C, Sciaky M, Cozzone PJ, Bernard M.

Transplant Proc. 2002 Jun;34(4):1259-61. No abstract available.

PMID:
12072333
10.

Sodium hydrosulfide improves the protective potential of the cardioplegic histidine buffer solution.

Alves MG, Soares AF, Carvalho RA, Oliveira PJ.

Eur J Pharmacol. 2011 Mar 1;654(1):60-7. doi: 10.1016/j.ejphar.2010.12.010. Epub 2010 Dec 24.

PMID:
21185822
11.

Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior.

Straatsburg IH, Abrahamse SL, Song SW, Hartman RJ, Van Gulik TM.

Transplantation. 2002 Aug 27;74(4):458-64.

PMID:
12352902
12.

Sub-normothermic preservation of donor hearts for transplantation using a novel solution, Somah: a comparative pre-clinical study.

Lowalekar SK, Cao H, Lu XG, Treanor PR, Thatte HS.

J Heart Lung Transplant. 2014 Sep;33(9):963-70. doi: 10.1016/j.healun.2014.05.006. Epub 2014 Jun 9.

PMID:
25001113
13.

Celsior preserved cardiac mechanoenergetics better than popular solutions in canine hearts.

Oshima Y, Mohri S, Shimizu J, Iribe G, Imaoka T, Fujinaka W, Kiyooka T, Ishino K, Sano S, Kajiya F, Suga H.

Ann Thorac Surg. 2006 Feb;81(2):658-64.

PMID:
16427870
14.

Advantages of Celsior solution in graft preservation from non-heart-beating donors in a canine liver transplantation model.

Ohwada S, Sunose Y, Aiba M, Tsutsumi H, Iwazaki S, Totsuka O, Matsumoto K, Takeyoshi I, Morishita Y.

J Surg Res. 2002 Feb;102(2):71-6.

PMID:
11796001
15.

Heart preservation with celsior solution improved by the addition of nitroglycerine.

Baxter K, Howden BO, Jablonski P.

Transplantation. 2001 May 27;71(10):1380-4.

PMID:
11391222
16.

A comparative study of Celsior and University of Wisconsin solutions based on 12-hr preservation followed by transplantation in canine models.

Mohara J, Morishita Y, Takahashi T, Oshima K, Yamagishi T, Takeyoshi I, Matsumoto K.

J Heart Lung Transplant. 1999 Dec;18(12):1202-10.

PMID:
10612379
17.

Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study.

Pietri S, Culcasi M, Albat B, Albérici G, Menasché P.

Transplantation. 1994 Sep 27;58(6):739-42. No abstract available.

PMID:
7940702
18.

Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution.

Watson AJ, Gao L, Sun L, Tsun J, Jabbour A, Ru Qiu M, Jansz PC, Hicks M, Macdonald PS.

J Heart Lung Transplant. 2013 Jun;32(6):633-40. doi: 10.1016/j.healun.2013.03.014.

PMID:
23701853
19.

Early reperfusion with warm, polarizing adenosine-lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage.

Rudd DM, Dobson GP.

J Thorac Cardiovasc Surg. 2011 Apr;141(4):1044-55. doi: 10.1016/j.jtcvs.2010.04.040. Epub 2010 Jul 4.

20.

[Prolonged preservation due to acceleration of anaerobic glycolysis with histidine buffered cardioplegia in canine heart].

Takeuchi K, Takashima K, Kawai A, Konishi H, Ohkado A, Suzuki S, del Nido PJ.

Nihon Kyobu Geka Gakkai Zasshi. 1995 Dec;43(12):1895-901. Japanese.

PMID:
8551068

Supplemental Content

Support Center